<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Capeding</surname>
    <given-names>R. Z.</given-names>
   </name>
   <name>
    <surname>Luna</surname>
    <given-names>I. A.</given-names>
   </name>
   <name>
    <surname>Bomasang</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Lupisan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Forrat</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2011</year>). 
  <article-title>Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines</article-title>. 
  <source>Vaccine</source>
  <volume>29</volume>, 
  <fpage>3863</fpage>â€“
  <lpage>3872</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.03.057</pub-id>
  <?supplied-pmid 21477675?>
  <pub-id pub-id-type="pmid">21477675</pub-id>
 </mixed-citation>
</ref>
